ABL Bio shares are surging for a second straight day on news that the company signed a technology transfer and joint research and development agreement with global pharmaceutical company Eli Lilly.
As of 10:59 a.m. on the 13th, ABL Bio stock was trading at 161,800 won on the KOSDAQ market, up 27.70% (35,100 won) from the previous day. Right after the open, it climbed as high as 162,200 won, up 28.02%, marking a 1-year high.
Earlier, on the 12th, ABL Bio disclosed that it had signed a technology transfer agreement with Eli Lilly. According to the filing, ABL Bio signed a Grabody-B platform technology transfer agreement with Eli Lilly. The deal size is about 3.0000000000000004 trillion won, and the upfront payment is about 58.528 billion won.
※ This article has been translated by AI. Share your feedback here.